Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) Net Income: 2018-2023

Historic Net Income for Therapeutics (RAPT) over the last 6 years, with Dec 2023 value amounting to -$127.1 million.

  • Therapeutics' Net Income fell 35.96% to -$33.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$127.1 million, marking a year-over-year decrease of 48.10%. This contributed to the annual value of -$127.1 million for FY2023, which is 48.10% down from last year.
  • As of FY2023, Therapeutics' Net Income stood at -$127.1 million, which was down 48.10% from -$85.8 million recorded in FY2022.
  • Therapeutics' 5-year Net Income high stood at -$43.0 million for FY2019, and its period low was -$127.1 million during FY2023.
  • Moreover, its 3-year median value for Net Income was -$85.8 million (2022), whereas its average is -$94.0 million.
  • Data for Therapeutics' Net Income shows a maximum YoY slumped of 48.10% (in 2023) over the last 5 years.
  • Over the past 5 years, Therapeutics' Net Income (Yearly) stood at -$43.0 million in 2019, then decreased by 23.01% to -$52.9 million in 2020, then tumbled by 30.84% to -$69.2 million in 2021, then declined by 23.97% to -$85.8 million in 2022, then tumbled by 48.10% to -$127.1 million in 2023.